survival

Open Access
Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation Therapy
YEI-TSUNG CHEN, PIN-YI CHEN, CHI-FEN CHANG, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, HAO-HAN CHANG, TE-LING LU, SHU-PIN HUANG and BO-YING BAO

Cancer Genomics & Proteomics November 2025, 22 (6) 991-1005; DOI: https://doi.org/10.21873/cgp.20551
Open Access
Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
SHU-PIN HUANG, BO-YING BAO, TA-HSIEN CHUANG, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, TE-LING LU and YEI-TSUNG CHEN

Cancer Genomics & Proteomics July 2025, 22 (4) 611-623; DOI: https://doi.org/10.21873/cgp.20525
Open Access
PRIM2: A Marker of MYC-driven Hyper-proliferation, Disease Progression, Tumor Aggressiveness and Poor Survival in Glioma Patients
RONGHUI SUN, XIAODONG SHAO, FARHANA AKTER, KASHIF RAFIQ ZAHID, SHUN YAO, LIANTING MA and GUOZHENG XU

Cancer Genomics & Proteomics March 2024, 21 (2) 186-202; DOI: https://doi.org/10.21873/cgp.20440
Open Access
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival
HYUNWOO YOO and HYUN-SOO KIM

Cancer Genomics & Proteomics November 2023, 20 (6) 626-636; DOI: https://doi.org/10.21873/cgp.20411
Open Access
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions
MICHELE MASSIMINO, STEFANIA STELLA, GIOVANNI MICALE, LUCIA MOTTA, GIULIANA PAVONE, GIUSEPPE BROGGI, ELIANA PIOMBINO, GAETANO MAGRO, HECTOR JOSE SOTO PARRA, LIVIA MANZELLA and PAOLO VIGNERI

Cancer Genomics & Proteomics May 2022, 19 (3) 350-361; DOI: https://doi.org/10.21873/cgp.20325
You have access
The Application of Bayesian Methods in Cancer Prognosis and Prediction
JIADONG CHU, NA SUN, WEI HU, XUANLI CHEN, NENGJUN YI and YUEPING SHEN

Cancer Genomics & Proteomics January 2022, 19 (1) 1-11; DOI: https://doi.org/10.21873/cgp.20298
You have access
PTBP1 Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate Cancer
SHU-PIN HUANG, LIH-CHYANG CHEN, YEI-TSUNG CHEN, CHENG-HSUEH LEE, CHAO-YUAN HUANG, CHIA-CHENG YU, VICTOR C. LIN, TE-LING LU and BO-YING BAO

Cancer Genomics & Proteomics May 2021, 18 (3) 325-334; DOI: https://doi.org/10.21873/cgp.20263
Open Access
Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype
STEVEN LEHRER, SHERYL GREEN, FRANCINE R. DEMBITZER, PETER H. RHEINSTEIN and KENNETH E. ROSENZWEIG

Cancer Genomics & Proteomics May 2019, 16 (3) 147-153; DOI: https://doi.org/10.21873/cgp.20120
Open Access
Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the SGK1 Gene Are Associated with Poorer Survival
STEVEN LEHRER, PETER H. RHEINSTEIN and KENNETH E. ROSENZWEIG

Cancer Genomics & Proteomics July 2018, 15 (4) 273-278; DOI: https://doi.org/10.21873/cgp.20085
Open Access
Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival
CATHERINE ZABKIEWICZ, JEYNA RESAUL, RACHEL HARGEST, WEN GUO JIANG and LIN YE

Cancer Genomics & Proteomics July 2017, 14 (4) 241-251;

Main menu

User menu

Search

survival

Pages